Page values for "Labetalol"

Nav

"Medicines" values

1 row is stored for this page

Field	Field type	Value
generic	`String`	Labetalol
brand	`String`	Trandate, Normodyne (discontinued in US)
structure	`File`
classes	List of `String`, delimiter: `,`	[[:Category:Beta blockers\|Combined alpha-1 and non-selective beta blocker]] • [[:Category:Antihypertensives\|Antihypertensive]]
mechanism	`String`	'"`UNIQ--vote-00000015-QINU`"' The favorable pregnancy safety profile and the dual mechanism support its first-line role in pregnancy-associated hypertension and in hypertensive emergencies where rapid, controllable BP reduction is needed'"`UNIQ--ref-00000016-QINU`"'.
uses	`String`	'"`UNIQ--vote-00000017-QINU`"', '"`UNIQ--vote-00000018-QINU`"', '"`UNIQ--vote-00000019-QINU`"'
starting_dose	`String`	Oral: 100 mg PO BID, titrate to 400 mg BID. IV: 20 mg over 2 minutes, repeat 40-80 mg every 10 minutes as needed (maximum cumulative 300 mg); continuous infusion 2 mg/minute
preparations	`String`	Tablets 100, 200, 300 mg; injection 5 mg/mL
fda_max	`String`	2400 mg/day (oral); 300 mg total per IV bolus dosing series
pill_id	`Text`
routes	List of `String`, delimiter: `,`	Oral • intravenous
onset	`String`	BP effect within hours (oral); 5-10 minutes (IV)
duration	`String`	8-12 hours (oral); 4-6 hours (IV)
halflife	`String`	~6-8 hours'"`UNIQ--ref-0000001A-QINU`"'
bioavailability	`String`	~25% (oral; extensive first-pass)'"`UNIQ--ref-0000001B-QINU`"'
pregnancy	`String`	'''Among the safest antihypertensives in pregnancy''', recommended for chronic hypertension during pregnancy and first-line for severe hypertension in preeclampsia and eclampsia'"`UNIQ--ref-0000001C-QINU`"'
legal	`String`	[[USLegal:Prescription only\|Rx-only]] in US